Compare ZTS & IMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZTS | IMO |
|---|---|---|
| Founded | 1952 | 1880 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.8B | 49.3B |
| IPO Year | 2013 | N/A |
| Metric | ZTS | IMO |
|---|---|---|
| Price | $126.64 | $116.53 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 2 |
| Target Price | ★ $164.18 | $115.00 |
| AVG Volume (30 Days) | ★ 5.0M | 647.0K |
| Earning Date | 02-12-2026 | 01-30-2026 |
| Dividend Yield | 1.67% | ★ 1.72% |
| EPS Growth | ★ 10.05 | N/A |
| EPS | ★ 6.02 | 4.73 |
| Revenue | $9,467,000,000.00 | ★ $34,335,433,802.00 |
| Revenue This Year | $5.77 | $13.79 |
| Revenue Next Year | $5.52 | $5.00 |
| P/E Ratio | ★ $21.04 | $25.34 |
| Revenue Growth | ★ 2.28 | N/A |
| 52 Week Low | $115.25 | $58.76 |
| 52 Week High | $177.00 | $120.02 |
| Indicator | ZTS | IMO |
|---|---|---|
| Relative Strength Index (RSI) | 53.85 | 66.98 |
| Support Level | $118.94 | $115.41 |
| Resistance Level | $132.49 | $119.96 |
| Average True Range (ATR) | 3.81 | 3.90 |
| MACD | 0.20 | 0.83 |
| Stochastic Oscillator | 59.04 | 83.50 |
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its USA business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Imperial Oil Ltd is an integrated oil company active in all phases of the petroleum industry in Canada, including the exploration for, and production and sale of, crude oil, natural gas, petroleum products, and petrochemicals. It also pursues lower-emission business opportunities, including carbon capture and storage, hydrogen, lower-emission fuels, and lithium. The company's reportable segments are Upstream, Downstream, and Chemical. Maximum revenue for the company is generated from its Downstream segment, which refines crude oil into petroleum products and distributes and market these products. The Upstream segment explores and produces crude oil, its equivalents, and natural gas, and the Chemical segment manufactures and markets hydrocarbon-based chemicals and chemical products.